Cystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cystic Fibrosis Clinical Trials Overview
The Cystic Fibrosis clinical trial report consists of 1285 trials. The report provides an overview of the Cystic Fibrosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Cystic Fibrosis. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report includes the names of prominent sponsors involved with conducting the Cystic Fibrosis clinical trials as well.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · The US
· The UK · Germany · Canada · Australia · France |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Vertex Pharmaceuticals Inc
· Cystic Fibrosis Foundation · Novartis AG · C. H. Boehringer Sohn AG & Co KG · Gilead Sciences Inc · Galapagos NV |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Cystic Fibrosis Clinical Trials Segmentation by Regions and Countries
Europe led the Cystic Fibrosis clinical trials landscape with more than 39% of the clinical trials conducted there as of October 2023.
The key regions considered for Cystic Fibrosis clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In a country-wise analysis, as of October 2023, the US accounted for the highest number of Cystic Fibrosis clinical trials, followed by the UK and Germany.
G7 countries: Among the G7 (United States, United Kingdom, Germany, Canada, Japan, France, and Italy) countries, France has the highest proportion of Cystic Fibrosis to Respiratory clinical trials as of October 2023.
E7 countries: Among the E7 (China, India, Russia, Turkey, Brazil, Mexico, and Indonesia) countries, Russia has the highest proportion of Cystic Fibrosis to Respiratory clinical trials as of October 2023.
Cystic Fibrosis Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Cystic Fibrosis Clinical Trials
Cystic Fibrosis Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Cystic Fibrosis clinical trials are company, institution, and the government. As of October 2023, the company sponsor type dominated the Cystic Fibrosis clinical trials share, followed by institution.
Cystic Fibrosis Clinical Trials Analysis by Sponsor Types, 2023 (%)
Buy Full Report for More Sponsor Type Insights into Cystic Fibrosis Clinical Trials
Cystic Fibrosis Clinical Trials - Competitive Landscape
In 2023, Vertex Pharmaceuticals Inc have conducted the highest number of Cystic Fibrosis clinical trials.
Some of the leading sponsors for Cystic Fibrosis clinical trials are:
- Vertex Pharmaceuticals Inc
- Cystic Fibrosis Foundation
- Novartis AG
- H. Boehringer Sohn AG & Co KG
- Gilead Sciences Inc
- Galapagos NV
Cystic Fibrosis Clinical Trials Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More About the Leading Players of Cystic Fibrosis Clinical Trials
Segments Covered in the Report
Cystic Fibrosis Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Cystic Fibrosis Clinical Trials Country Outlook (2023)
- The US
- The UK
- Germany
- Canada
- Australia
- France
Cystic Fibrosis Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Cystic Fibrosis Foundation
Novartis AG
C. H. Boehringer Sohn AG & Co KG
Gilead Sciences Inc
Galapagos NV
F. Hoffmann-La Roche Ltd
AbbVie Inc
Merck & Co Inc
Kineta Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Cystic Fibrosis clinical trials?
Europe accounted for the highest number of Cystic Fibrosis clinical trials as of October 2023.
-
Which country conducted the highest number of Cystic Fibrosis clinical trials?
The US conducted the highest number of Cystic Fibrosis clinical trials as of October 2023.
-
Which sponsor type was the most prominent in the Cystic Fibrosis clinical trials?
Company was the most prominent sponsor type for Cystic Fibrosis clinical trials.
-
Who are the leading sponsors of Cystic Fibrosis clinical trials?
Some of the leading sponsors of Cystic Fibrosis clinical trials are Vertex Pharmaceuticals Inc, Cystic Fibrosis Foundation, Novartis AG, C. H. Boehringer Sohn AG & Co KG, Gilead Sciences Inc, and Galapagos NV, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.